Padte Smitesh, Mehta Priyal, Bansal Vikas, Singh Niti, Sunasra Rayyan, Goyal Vidhi, Chaudhary Raunaq B, Junnarkar Yash, Shah Vidhi, Arshad Zara, Nawaz Faisal A, Surani Salim, Kashyap Rahul
Department of Research, Global Remote Research Scholar Program, Princeton Junction, Princeton, NJ 08550, United States.
Department of Internal Medicine, WellSpan York Hospital, York, PA 17403, United States.
World J Crit Care Med. 2024 Dec 9;13(4):99564. doi: 10.5492/wjccm.v13.i4.99564.
Pulmonary hypertension (PH) is a progressive disease characterized by endothelial dysfunction and vascular remodeling and is a leading cause of mortality worldwide. Although it is independently associated with multiple comorbidities, the impact of diabetes mellitus (DM) on mortality in patients with PH remains uncertain. To address this issue, we conducted a systematic review and meta-analysis to investigate the effect of DM on survival in patients with pulmonary hypertension.
To investigate the impact of diabetes mellitus on mortality in pulmonary hypertension patients.
We conducted a comprehensive search of four major electronic bibliographic databases like PubMed, Google Scholar, Scopus, and Embase, and identified 106 relevant studies, out of 1561 articles, published since the year 2000 for full-text review. Fourteen retrospective and prospective cohort studies that compared survival between patients with DM and those without DM in the context of PH were deemed eligible for inclusion in our meta-analysis. The study was registered on PROSPERO with the identifier CRD42023390232.
A total of 116455 patients with PH were included in the meta-analysis, of whom 41228 suffered from DM and 75227 did not. The results of our meta-analysis indicate an elevated mortality rate among PH patients with diabetes mellitus in comparison to those without DM [odds ratio (OR) = 1.40, 95%CI: 1.15-1.70, = 0.0006]. The meta-regression analysis unveiled a statistically significant negative association between mean age and effect size (coefficient = -0.036, value = 0.018). Conversely, a statistically significant positive association was detected between female proportion and effect size (coefficient = 0.000, value < 0.001).
Our meta-analysis, which included approximately 116500 PH patients, revealed that the presence of diabetes mellitus was associated with increased odds of mortality when compared to non-diabetic patients. The meta-regression analysis indicates that studies with older participants and lower proportions of females tend to exhibit smaller effect sizes. Clinically, these findings underscore the importance of incorporating diabetes status into the risk stratification of patients with PH with more aggressive monitoring and early intervention to improve prognosis potentially.
肺动脉高压(PH)是一种以血管内皮功能障碍和血管重塑为特征的进行性疾病,是全球范围内导致死亡的主要原因。尽管它与多种合并症独立相关,但糖尿病(DM)对PH患者死亡率的影响仍不确定。为解决这一问题,我们进行了一项系统评价和荟萃分析,以研究DM对肺动脉高压患者生存的影响。
研究糖尿病对肺动脉高压患者死亡率的影响。
我们全面检索了四个主要的电子文献数据库,如PubMed、谷歌学术、Scopus和Embase,并在1561篇文章中确定了106项相关研究,这些研究自2000年以来发表,以供全文审查。14项回顾性和前瞻性队列研究比较了PH患者中糖尿病患者和非糖尿病患者的生存率,被认为符合纳入我们荟萃分析的条件。该研究已在PROSPERO上注册,标识符为CRD42023390232。
荟萃分析共纳入116455例PH患者,其中41228例患有DM,75227例未患DM。我们的荟萃分析结果表明,与非糖尿病的PH患者相比,糖尿病PH患者的死亡率有所升高[优势比(OR)=1.40,95%置信区间:1.15-1.70,P=0.0006]。荟萃回归分析显示,平均年龄与效应大小之间存在统计学显著的负相关(系数=-0.036,P值=0.018)。相反,女性比例与效应大小之间存在统计学显著的正相关(系数=0.000,P值<0.001)。
我们的荟萃分析纳入了约116500例PH患者,结果显示,与非糖尿病患者相比,糖尿病的存在与死亡几率增加相关。荟萃回归分析表明,参与者年龄较大且女性比例较低的研究往往效应大小较小。在临床上,这些发现强调了将糖尿病状态纳入PH患者风险分层的重要性,通过更积极的监测和早期干预可能改善预后。